BIOMAT Database Logo BIOMAT Database Logo

Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. 2003

Songtao Yu, and Kimihiko Matsusue, and Papreddy Kashireddy, and Wen-Qing Cao, and Vaishalee Yeldandi, and Anjana V Yeldandi, and M Sambasiva Rao, and Frank J Gonzalez, and Janardan K Reddy
Department of Pathology, Northwestern University, the Feinberg School of Medicine, Chicago, Illinois 60611-3008, USA.

Peroxisome proliferator activated-receptor (PPAR) isoforms, alpha and gamma, function as important coregulators of energy (lipid) homeostasis. PPARalpha regulates fatty acid oxidation primarily in liver and to a lesser extent in adipose tissue, whereas PPARgamma serves as a key regulator of adipocyte differentiation and lipid storage. Of the two PPARgamma isoforms, PPARgamma1 and PPARgamma2 generated by alternative splicing, PPARgamma1 isoform is expressed in liver and other tissues, whereas PPARgamma2 isoform is expressed exclusively in adipose tissue where it regulates adipogenesis and lipogenesis. Since the function of PPARgamma1 in liver is not clear, we have, in this study, investigated the biological impact of overexpression of PPARgamma1 in mouse liver. Adenovirus-PPARgamma1 injected into the tail vein induced hepatic steatosis in PPARalpha(-/-) mice. Northern blotting and gene expression profiling results showed that adipocyte-specific genes and lipogenesis-related genes are highly induced in PPARalpha(-/-) livers with PPARgamma1 overexpression. These include adipsin, adiponectin, aP2, caveolin-1, fasting-induced adipose factor, fat-specific gene 27 (FSP27), CD36, Delta(9) desaturase, and malic enzyme among others, implying adipogenic transformation of hepatocytes. Of interest is that hepatic steatosis per se, induced either by feeding a diet deficient in choline or developing in fasted PPARalpha(-/-) mice, failed to induce the expression of these PPARgamma-regulated adipogenesis-related genes in steatotic liver. These results suggest that a high level of PPARgamma in mouse liver is sufficient for the induction of adipogenic transformation of hepatocytes with adipose tissue-specific gene expression and lipid accumulation. We conclude that excess PPARgamma activity can lead to the development of a novel type of adipogenic hepatic steatosis.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D005234 Fatty Liver Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. Liver Steatosis,Steatohepatitis,Steatosis of Liver,Visceral Steatosis,Liver Steatoses,Liver, Fatty,Steatohepatitides,Steatoses, Liver,Steatoses, Visceral,Steatosis, Liver,Steatosis, Visceral,Visceral Steatoses
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D000071438 Fatty Acid-Binding Protein 7 A fatty acid-binding protein expressed by ASTROCYTES during CENTRAL NERVOUS SYSTEM development, and by MALIGNANT GLIOMA cells. It is also expressed by ASTROCYTES in response to injury or ISCHEMIA, and may function in repair of the MYELIN SHEATH. Brain Lipid-Binding Protein,Fatty Acid-Binding Protein, Brain,Mammary-Derived Growth Inhibitor Related Protein,Brain Lipid Binding Protein,Fatty Acid Binding Protein 7,Fatty Acid Binding Protein, Brain,Lipid-Binding Protein, Brain,Mammary Derived Growth Inhibitor Related Protein

Related Publications

Songtao Yu, and Kimihiko Matsusue, and Papreddy Kashireddy, and Wen-Qing Cao, and Vaishalee Yeldandi, and Anjana V Yeldandi, and M Sambasiva Rao, and Frank J Gonzalez, and Janardan K Reddy
Differential regulation of peroxisome proliferator activated receptor gamma1 (PPARgamma1) and PPARgamma2 messenger RNA expression in the early stages of adipogenesis.
January 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research,
Songtao Yu, and Kimihiko Matsusue, and Papreddy Kashireddy, and Wen-Qing Cao, and Vaishalee Yeldandi, and Anjana V Yeldandi, and M Sambasiva Rao, and Frank J Gonzalez, and Janardan K Reddy
Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation.
June 2000, Biochimica et biophysica acta,
Songtao Yu, and Kimihiko Matsusue, and Papreddy Kashireddy, and Wen-Qing Cao, and Vaishalee Yeldandi, and Anjana V Yeldandi, and M Sambasiva Rao, and Frank J Gonzalez, and Janardan K Reddy
Molecular cloning and characterisation of peroxisome proliferator activated receptor gamma1 (PPARgamma1) cDNA gene from guinea pig (Cavia porcellus): tissue distribution.
January 2003, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology,
Songtao Yu, and Kimihiko Matsusue, and Papreddy Kashireddy, and Wen-Qing Cao, and Vaishalee Yeldandi, and Anjana V Yeldandi, and M Sambasiva Rao, and Frank J Gonzalez, and Janardan K Reddy
Expression of peroxisome proliferator-activated receptor-gamma1 and peroxisome proliferator-activated receptor-gamma2 in visceral and subcutaneous adipose tissue of obese women.
July 2003, Diabetes,
Songtao Yu, and Kimihiko Matsusue, and Papreddy Kashireddy, and Wen-Qing Cao, and Vaishalee Yeldandi, and Anjana V Yeldandi, and M Sambasiva Rao, and Frank J Gonzalez, and Janardan K Reddy
Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma.
October 1995, Current opinion in genetics & development,
Songtao Yu, and Kimihiko Matsusue, and Papreddy Kashireddy, and Wen-Qing Cao, and Vaishalee Yeldandi, and Anjana V Yeldandi, and M Sambasiva Rao, and Frank J Gonzalez, and Janardan K Reddy
Activated liver X receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor gamma expression.
April 2004, Molecular and cellular biology,
Songtao Yu, and Kimihiko Matsusue, and Papreddy Kashireddy, and Wen-Qing Cao, and Vaishalee Yeldandi, and Anjana V Yeldandi, and M Sambasiva Rao, and Frank J Gonzalez, and Janardan K Reddy
Peroxisome proliferator-activated receptor α agonist-induced histidine decarboxylase gene expression in the rat and mouse liver.
January 2020, The Journal of toxicological sciences,
Songtao Yu, and Kimihiko Matsusue, and Papreddy Kashireddy, and Wen-Qing Cao, and Vaishalee Yeldandi, and Anjana V Yeldandi, and M Sambasiva Rao, and Frank J Gonzalez, and Janardan K Reddy
Transcriptional regulation of adipogenin expression in liver steatosis by hepatic peroxisome proliferator-activated receptor gamma.
August 2023, Genes to cells : devoted to molecular & cellular mechanisms,
Songtao Yu, and Kimihiko Matsusue, and Papreddy Kashireddy, and Wen-Qing Cao, and Vaishalee Yeldandi, and Anjana V Yeldandi, and M Sambasiva Rao, and Frank J Gonzalez, and Janardan K Reddy
The ontogeny of peroxisome-proliferator-activated receptor gene expression in the mouse and rat.
February 1992, Proceedings. Biological sciences,
Songtao Yu, and Kimihiko Matsusue, and Papreddy Kashireddy, and Wen-Qing Cao, and Vaishalee Yeldandi, and Anjana V Yeldandi, and M Sambasiva Rao, and Frank J Gonzalez, and Janardan K Reddy
Peroxisome proliferator activated receptor-alpha expression in human liver.
January 1998, Molecular pharmacology,
Copied contents to your clipboard!